E-health in inflammatory bowel diseases: More challenges than opportunities?

Bossuyt P1, Pouillon L2, Bonnaud G3, Danese S4, Peyrin-Biroulet L5. Dig Liver Dis. 2017 Aug 24. pii: S1590-8658(17)31034-4. doi: 10.1016/j.dld.2017.08.026. [Epub ahead of print]
Author information

1 Imelda GI clinical research centre, Imelda General Hospital Bonheiden, Bonheiden, Belgium. Electronic address: peter.bossuyt@imelda.be. 2 Department of Hepato-Gastroenterology, University Hospitals Gasthuisberg Leuven, Leuven, Belgium. 3 Department of Hepato-Gastroenterology, Ambroise Paré Clinic, Toulouse, France. 4 Department of Biomedical Sciences, Humanitas University, Milan, Italy; IBD Center, Department of Gastroenterology, Humanitas Clinical and Research Center, Milan, Italy. 5 Inserm U954 and Department of Gastroenterology, Nancy University Hospital, University of Lorraine, Vandoeuvre-lès-Nancy, France.


Patients with inflammatory bowel disease need close monitoring for an optimal disease management. For this, e-health technologies are promising tools. But the current evidence for the implementation of e-health in inflammatory bowel disease is weak. For this a critical evaluation of the existing evidence is presented. Furthermore some essential conditions need to be full-filled. We need a robust digital infrastructure that is workable for the patient and the healthcare provider. Important legal issues need to be solved to protect the patient. And the e-health technologies will have to proof their durability, feasibility and acceptance for the patient on the long term.

© Copyright 2013-2024 GI Health Foundation. All rights reserved.
This site is maintained as an educational resource for US healthcare providers only. Use of this website is governed by the GIHF terms of use and privacy statement.